Portal Hypertension: Pathophysiology, Diagnosis, and Treatment

Journal of Veterinary Internal Medicine

Volumn 25, Issue 2, 2011, Pages 169-186

  Buob, S ^a   Johnston, A N ^a   Webster, C R L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Ascites; Cirrhosis; Hepatic disease; Portosystemic shunts

Indexed keywords

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; DOG; DOG DISEASE; HISTOLOGY; LIVER; LIVER CIRCULATION; PATHOLOGY; PHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN; REVIEW; VASCULARIZATION;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; HYPERTENSION, PORTAL; LIVER; LIVER CIRCULATION; PORTAL SYSTEM;

EID: 79952322816     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.00691.x     Document Type: Review

References (194)

1. Raffan E, McCallum A, Scase TJ, Watson PJ. Ascites is a negative prognostic indicator in chronic hepatitis in dogs. J Vet Intern Med 2009;23:63-66.
2. Sevelius E. Diagnosis and prognosis of chronic hepatitis and cirrhosis in dogs. J Small Anim Pract 1995;36:521-528.
3. Poldervaart JH, Favier RP, Penning LC, et al. Primary hepatitis in dogs: A retrospective review (2002-2006). J Vet Intern Med 2009;23:72-80.
4. Johnson SE. Portal hypertension. Part I. Pathophysiology and clinical consequences. Compend Continuing Educ Pract Vet 1987;9:741-748.
5. Johnson SE. Portal hypertension. Part II. Clinical assessment and treatment. Compend Continuing Educ Pract Vet 1987;9:917-925.
6. Hess PR, Bunch SE. Management of portal hypertension and its consequences. Vet Clin North Am Small Anim Pract 1995;25:461-483.
7. Berent AC, Tobias KM. Portosystemic vascular anomalies. Vet Clin North Am Small Anim Pract 2009;39:513-541.
8. Rothuzien J, Bunch SE, Charles JA, et al., eds. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases, 1st ed. Philadelphia, PA: WB Saunders Elsevier; 2006.
9. Schmidt S, Lohse CL, Suter PF. Branching patterns of the hepatic artery in the dog; Arteriographic and anatomic study. Am J Vet Res 1980;41:1090-1097.
10. Iwakiri Y, Goszmann RJ. The hyperdynamic circulation of chronic liver diseases: From patient to the molecule. Hepatology 2006;43:S121-S131.
11. Bosch J, Abraldes JG, Fernández M, García-Pagán JC. Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension. J Hepatol 2010;53:558-567.
12. Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology 2008;134:1715-1728.
13. Laleman W, Van Landeghem L, Wilmer A, et al. Portal hypertension: From pathophysiology to clinical practice. Liver Int 2005;25:1079-1090.
14. Jin W, Deng L, Zhang Q, et al. A canine portal hypertension model induced by intra-portal administration of sephadex microsphere. J Gastroenterol Hepatol 2010;25:778-785.
15. Kinoshita G, Washizu M, Kondo M, et al. Effect of food on liver circulation in conscious dog. J Vet Med Sci 1995;57:323-326.
16. Schmidt S, Suter HF. Indirect and direct determination of portal vein pressure in normal and abnormal dogs and normal cats. Vet Rad 1980;21:246-259.
17. Ezzat WR, Lautt WW. Hepatic arterial pressure-flow autoregulation is adenosine mediated. Am J Physiol 1987;252:836-845.
18. Friedman EW, Weiner RS. Estimation of hepatic sinusoid pressure by means of venous catheters and estimation of portal pressure by hepatic vein catheterization. Am J Physiol 1951;165:527-531.
19. Fujita Y, Sakai T, Ohsumi A, Takaori M. Effects of hypocapnia on splanchinic circulation and hepatic function in the Beagle. Anesth Analog 1989;69:152-157.
20. Halmagyi DFJ, Goodman AH, Little MJ, et al. Portal blood flow and oxygen usage in dogs after hemorrhage. Ann Surg 1970;172:284-290.
21. Mizner W. Hepatic outflow resistance, sinusoid pressure, and the vascular waterfall. Am J Physiol 1974;227:513-519.
22. Chen Y, Zhang Q, Liao Y, et al. A modified canine model of portal hypertension with hypersplenism. Scan J Gastroenterol 2009;44:478-485.
23. Fang HP, Deng MH, Lin N, et al. A novel canine model of esophageal varices with a balloon dilatation constrictor. Dig Dis Sci 2009;54:1449-1455.
24. Li XQ, Dong L, Luo JY. Effects of different infusion volumes on hemodynamics of portal hypertension in canines after hemorrhagic shock. J Hepatobiliary Pancreat Dis Int 2004;3:571-576.
25. Yao XX, Cui DL, Feng SY, Li XT. Clinical and experimental study of effect of roandix salviae miltiorrhiza and other blood activating and stasis-eliminating Chinese herbs on hemodynamics of portal hypertension. World J Gastroenterol 1998;4:439-442.
26. Boothe HW, Howe LM, Edwards JF, Slater MR. Multiple extrahepatic portosystemic shunts in dogs: 30 cases (1981-1993). J Am Vet Med Assoc 1996;208:1849-1854.
27. Seaman KL, Greenway CV. Loss of hepatic venous responsiveness after endotoxin in anesthetized cats. Am J Physiol Heart Circ Physiol 1984;15:H658-H663.
28. Lautt WE, Greenway CV, Legare DJ, Weisman H. Localization of intrahepatic portal vascular resistance. Am J Physiol Gastrointest Liver Physiol 1986;14:G375-G381.
29. Lautt WW, Legare DJ, Turner GA. Evaluation of hepatic venous balloon occluder to estimate portal pressure. Clin Invest Med 1990;13:247-255.
30. Lautt WW, Legare DJ. Passive autoregulation of portal venous pressure: Distensible hepatic resistance. Am J Physiol Gastrointest Liver Physiol 1992;26:G702-G708.
31. Frankel D, Seim H, MacPhail C, Monnet E. Evaluation of cellophane banding with and without intraoperative attenuation for treatment of congenital extrahepatic portosystemic shunts in dogs. J Am Vet Med Assoc 2006;228:1355-1360.
32. Worley DR, Holt DE. Clinical outcome of congenital extrahepatic portosystemic shunt attenuation in dogs aged five years and older: 17 cases (1992-2005). J Am Vet Med Assoc 2008;232:722-727.
33. Murphy ST, Ellison GW, Long M, Van Gilder J. A comparison of the ameroid constrictor versus ligation in the surgical management of single extrahepatic portosystemic shunts. J Am Anim Hosp Assoc 2001;37:390-396.
34. Hottinger HA, Walshaw R, Hauptman JG. Long-term results of complete and partial ligation of congenital portosystemic shunts in dogs. Vet Surg 1995;24:331-336.
35. Mehl ML, Kyles AE, Hardie EM, et al. Evaluation of ameroid ring constrictors for treatment for single extrahepatic portosystemic shunts in dogs: 168 cases (1995-2001). J Am Vet Med Assoc 2005;226:2020-2030.
36. Mehl ML, Kyles AE, Case JB, et al. Surgical management of left-divisional intrahepatic portosystemic shunts: Outcome after partial ligation of, or ameroid ring constrictor placement on, the left hepatic vein in twenty-eight dogs (1995-2005). Vet Surg 2007;36:21-30.
37. Lee KC, Lipscomb VJ, Lamb CR, et al. Association of portovenographic findings with outcome in dogs receiving surgical treatment for single congenital portosystemic shunts: 45 cases (2000-2004). J Am Vet Med Assoc 2006;229:1122-1129.
38. Matthews K, Gofton N. Congenital extrahepatic portosystimc shunt occlusion in the dog: Gross observation during surgical correction. J Am Vet Med Assoc 1988;24:387-394.
39. Lipscomb VJ, Lee KC, Lamb CR, Brockman DJ. Association of mesenteric portovenographic findings with outcome in cats receiving surgical treatment for single congenital portosystemic shunts. J Am Vet Med Assoc 2009;234:221-228.
40. Havig M, Tobias KM. Outcome of ameroid constrictor occlusion of single congenital extrahepatic portosystemic shunts in cats: 12 cases (1993-2000). J Am Vet Med Assoc 2002;220:337-341.
41. Kyles AE, Hardie EM, Mehl M, Gregory CR. Evaluation of ameroid ring constrictors for the management of single extrahepatic portosystemic shunts in cats: 23 cases (1996-2001). J Am Vet Med Assoc. 2002;220:1341-1137.
42. VanGundy TE, Boothe HW, Wolf A. Results of surgical management of feline portosystemic shunts. J Am Anim Hosp Assoc 1990;26:55-62.
43. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573-582.
44. Cohn LA, Spaulding KA, Cullen JM, et al. Intrahepatic post-sinusoidal venous obstruction in a dog. J Vet Intern Med 1991;5:317-321.
45. Singal AK, Ahmad M, Soloway RD. Duplex Doppler ultrasound examination of the portal venous system: An emerging novel technique for the estimation of portal vein pressure. Dig Dis Sci 2010;55:1230-1240.
46. Swalec KM, Smeak DD, Brown J. Effects of mechanical and pharmacologic manipulations on portal pressure, central venous pressure, and heart rate in dogs. Am J Vet Res 1991;52:1327-1335.
47. VanWinkle TJ, Bruce E. Thrombosis of the portal vien in 11 dogs. Vet Pathol 1993;30:28-35.
48. James F, Knowles GW, Mansfield CS, Robertson ID. Ascites due to pre-sinusoidal portal hypertension in dogs: A retrospective analysis of 17 cases. Aust Vet J 2008;86:180-186.
49. Szatmari V, van den Ingh TS, Fenyves B, Sotonyi R. Portal hypertension in a dog due to circumscribed fibrosis of the wall of the extrahepatic portal vein. Vet Rec 2002;150:602-605.
50. Ewing GO, Suter PF, Bailey CS. Hepatic insufficiency associated with congenital anomalies of the portal vein in dogs. J Am Anim Hosp Assoc 1974;10:463-476.
51. van den Ingh TS, Rothuizen J, Meyer HP. Portal hypertension associated with primary hypoplasia of the portal vein in dogs. Vet Rec 1995;137:424-427.
52. McConnell JF, Sparkes AH, Ladlow J, et al. Ultrasound diagnosis of unusual portovenous abnormalities in 2 cats. J Small Anim Prac 2006;47:338-343.
53. Chanoit G, Kyles AE, Weisse C, Hardie EM. Surgical and interventional radiographic treatment of dogs with hepatic arteriovenouse fistulae. Vet Surg 2007;36:199-209.
54. Bailey MG, Willard MD, McLough MA, et al. Ultrasonographic findings associated with congenital hepatic arteriovenous fistula in three dogs. J Am Vet Med Assoc 1988;192:1099-1101.
55. Legendre AM, Krahwinkel DJ, Carrig CB, Michel RL. Ascites associated with intrahepatic arteriovenous fistula in a cat. J Am Vet Med Assoc 1976;168:589-591.
56. Harmanci O, Bayraktar Y. Clinical characteristics of idiopathic portal hypertension. World J Gastroenterol 2007;13:1906-1911.
57. van den Ingh TS, Rothuizen J. Hepatoportal fibrosis in three young dogs. Vet Rec 1982;110:575-577.
58. McEntee MF, Wright KN, Wanless I, et al. Noncirrhotic portal hypertension and nodular regenerative hyperplasia of the liver in dogs with mucopolysaccharidosis type I. Hepatology 1998;28:385-390.
59. Bunch SE, Johnson SE, Cullen JM. Idiopathic noncirrhotic portal hypertension in dogs: 33 cases (1982-1998). J Am Vet Med Assoc 2001;218:392-399.
60. DeMarco J, Center SA, Dykes N, et al. A syndrome resembling idiopathic noncirrhotic portal hypertension in 4 young Doberman Pinschers. J Vet Intern Med 1998;12:147-156.
61. Cornelius LM, Thrall DE, Halliwell WH, et al. Anomalous portosystemic anastomoses associated with chronic hepatic insufficiency in 6 young dogs. J Am Vet Med Assoc 1975;167:220-228.
62. Rand JS, Best SJ, Mathews K. Portosystemic vascular shunts in a family of American Cocker Spaniels. J Am Anim Hosp Assoc 1988;24:265-272.
63. Rutgers HC, Haywood S, Kelly DF. Idiopathic hepatic fibrosis in 15 dogs. Vet Rec 1993;133:115-228.
64. Brown DL, Van Winkle T, Cecere T, et al. Congenital hepatic fibrosis in 5 dogs. Vet Pathol 2010;47:102-107.
65. Görlinger S, Rothuizen J, Bunch S, van den Ingh TS. Congenital dilatation of the bile ducts (Caroli's disease) in young dogs. J Vet Intern Med 2003;17:28-32.
66. McKenna SC, Carpenter JL. Polycystic disease of the kidney and liver in the Cairn Terrier. Vet Pathol 1980;17:436-442.
67. Bosje JT, van den Ingh TS, van der Linde-Sipman JS. Polycystic kidney and liver disease in cats. Vet Q 1998;20:136-139.
68. Zandvliet MM, Szatmári V, van den Ingh TS, Rothuizen J. Acquired portosystemic shunting in 2 cats secondary to congenital hepatic fibrosis. J Vet Intern Med 2005;19:765-767.
69. Flowers JR, Hammerberg B, Wood SL, et al. Heterobilharzia americana infection in a dog. J Am Vet Med Assoc 2002;220:193-196.
70. Favier RP. Idiopathic hepatitis and cirrhosis in dogs. Vet Clin North Amer Small Anim Pract 2009;39:481-488.
71. Hoffman G. Copper associated liver disease. Vet Clin North Am Small Anim Pract 2009;39:489-512.
72. Bergman JR. Nodular hyperplasia in the liver of the dog: An association with changes in the Ito cell population. Vet Pathol 1985;22:427-438.
73. Harada A, Nakanuma Y, Govindarajan S, Peters RL. Nodular regenerative hyperplasia of the liver with and without portal hypertension: A comparison. Ann Clin Lab Sci 1986;16:155-162.
74. Bayraktar UD, Seren S, Bayraktar Y. Hepatic venous outflow obstruction: Three similar syndromes. World J Gastroenterol 2007;13:1912-1927.
75. Shulman HM, Luk K, Deeg HJ, et al. Induction of hepatic veno-occlusive disease in dogs. Am J Pathol 1987;126:114-125.
76. Epstein RB, Min KW, Anderson SL, Syzek L. A canine model for hepatic venoocclusive disease. Transplantation 1992;54:12-16.
77. Cave TA, Martineau H, Dickie A, Thompson H, Argyle DJ. Idiopathic hepatic veno-occlusive disease causing Budd-Chiari like syndrome in a cat. J Small Anim Pract 2002;43:411-415.
78. Fredholm D. Multiple acquired extrahepatic portosystemic shunts secondary to veno-occlusive disease in a young German Shepherd. Can Vet J 2009;50:763-766.
79. Dunning D, Monnet E, Orton EC, Salman MD. Analyis of prognostic indicators in dogs with pericardial effusion: 49 cases (1985-1996). J Am Vet Med Assoc 1998;212:1276-1280.
80. Thomas WP, Reed JR, Bauer TG, Breznock EM. Constrictive pericardial disease in the dog. J Am Vet Med Assoc 1984;184:546-553.
81. Stafford Johnson M, Martin M, Binns S, Day MJ. A retrospective study of clinical findings, treatment and outcome in 143 dogs with pericardial effusion. J Small Anim Pract 2004;45:546-552.
82. Whelan MF, O'Toole TE, Carlson KR, et al. Budd-Chiari-like syndrome in a dog with a chondrosarcoma of the thoracic wall. J Vet Emerg Crit Care 2007;17:175-178.
83. Mitchell MC, Boitnott JK, Kaufman S, et al. Budd-Chiari syndrome: Etiology, diagnosis and management. Medicine 1982;61:199-218.
84. Macintire DK, Henderson RH, Banfield C, Kwapien RP. Budd-Chiari syndrome in a kitten, caused by membranous obstruction of the caudal vena cava. J Am Anim Hosp Assoc 1995;31:484-491.
85. Lang LL. Budd-Chiari syndrome in a dog due to liver lobe entrapment within the falciform ligament. J Am Anim Hosp Assoc 2009;45:253-256.
86. Schlicksup MD, Weisse CW, Berent AC, Solomon JA. Use of endovascular stents in 3 dogs with Budd-Chiari syndrome. J Am Vet Med Assoc 2009;235:544-550.
87. Miller MW, Bonagura JD, DiBartola S, Fossum T. Budd-Chiari syndrome in two dogs. J Am Anim Hosp Assoc 1989;25:277-284.
88. Schoeman JP, Stidworthy MF. Budd-Chiari syndrome associated with an adrenal phaeochromocytoma in a dog. J Small Anim Pract 2001;442:191-194.
89. Baig MA, Gemmil T, Hammond G, et al. Budd-Chiari like syndrome caused by a congenital hiatal hernia in a Shar-Pei dog. Vet Rec 2006;159:322-323.
90. Hennenberg M, Tebicka J, Sauerbruch T, Heller J. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut 2008;57:1300-1314.
91. Rasaratnam B, Connelly N, Chin-Dusting J. Nitric oxide and the hyperdynamic circulation in cirrhosis: Is there a role for selective intestinal decontamination? Clin Sci 2004;107:425-434.
92. Fernandez M, Semela D, Bruix J, et al. Angiogenesis in liver disease. J Hepatol 2009;50:604-620.
93. Leiva JG, Salgado JM, Estradas J, et al. Pathophysiology of ascites and dilutional hyponatremia: Contemporary use of aquaretic agents. Ann Hepatol 2007;6:214-221.
94. Hou W, Sanyal AJ. Ascites: Diagnosis and management. Med Clin North Am 2009;93:801-817.
95. Bosch J, Enriquez R, Groszmann RJ, Storer EH. Chronic bile duct ligation in the dog: Hemodynamic characterization of a portal hypertensive model. Hepatology 1983;3:1002-1007.
96. Howe LM, Boothe HW Jr, Miller MW, Boothe DM. A canine model of multiple portosystemic shunting. J Invest Surg 2000;13:45-57.
97. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Eng J Med 2010;362:823-832.
98. Bertolini G, De Lorenzi D, Ledda G, Caldin M. Esophageal varices due to a probable arteriovenous communication in a dog. J Vet Intern Med 2007;21:1392-1395.
99. Jensen DM, Machicado GA, Tapia JI, et al. A reproducible canine model of esophageal varices. Gastroenterology 1983;84:573-579.
100. Bertolini G. Acquired portal collateral circulation in the dog and cat. Vet Radiol Ultrasound 2010;51:25-33.
101. Eroglu Y, Byrne WJ. Hepatic encephalopathy. Emerg Med Clin North Am 2009;27:401-414.
102. Rothuizen J. Important clinical syndromes associated with liver disease. Vet Clin North Am Small Anim Pract 2009;39:419-437.
103. Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008;57:1156-1165.
104. Moreau R. Hyponatremia in cirrhosis. Pathophysiology, prevalence, prognostic value, treatment. Acta Gastroenterol Belg 2008;71:379-386.
105. Munoz SJ. The hepatorenal syndrome. Med Clin North Am 2008;92:813-837.
106. McCormick PA, Donnelly C. Management of hepatorenal syndrome. Pharmacol Ther 2008;119:1-6.
107. Cornelius CE, Himes JA, Gronwall RR. Experimental liver diseases. Methods Achiev Exp Pathol 1975;7:22-55.
108. Kasai Y, Kawanishi N. Clinical and experimental study on hepatorenal syndrome in terms of obstructive jaundice. Hokkaido Igaku Zasshi 1978;53:147-155.
109. Umeda N, Kamath PS. Hepatopulmonary syndrome and portopulmonary hypertension. Hepatol Res 2009;39:1020-1022.
110. Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N Engl J Med 2008;358:2378-2387.
111. Singh C, Sager JS. Pulmonary complications of cirrhosis. Med Clin North Am 2009;93:871-883.
112. Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol 2010;23:145-150.
113. Gustot T, Durand F, Lebrec D, et al. Severe sepsis in cirrhosis. Hepatology 2009;50:2022-2033.
114. Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: A severe complication of liver cirrhosis. World J Gastroenterol 2009;15:5505-5510.
115. Culp WT, Zeldis TE, Reese MS, Drobatz KJ. Primary bacterial peritonitis in dogs and cats: 24 cases (1990-2006). J Am Vet Med Assoc 2009;234:906-913.
116. Ruthrauff CM, Smith J, Glerum L. Primary bacterial septic peritonitis in cats: 13 cases. J Am Anim Hosp Assoc 2009;45:268-276.
117. Szatmári V, Rothuizen J, van den Ingh TS, et al. Ultrasonographic findings in dogs with hyperammonemia: 90 cases. J Am Vet Med Assoc 2004;224:717-727.
118. Merli M, Nicolini G, Angeloni S, et al. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 2004;99:1959-1965.
119. Henderson AK, Webster CRL. Disruption of the gastric mucosal barrier in dogs. Compend Continuing Educ Pract Vet 2006;28:340-357.
120. Stanton ME, Bright RM. Gastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature review. J Vet Intern Med 1989;3:238-244.
121. Laflamme DP, Mahaffey EA, Allen SW, et al. Microcytosis and iron status in dogs with surgically induced portosystemic shunts. J Vet Intern Med 1994;8:212-216.
122. Simpson KW, Meyer DJ, Boswood A, et al. Iron status and erythrocyte volume in dogs with congenital portosystemic vascular anomalies. J Vet Intern Med 1997;11:14-19.
123. Prins M, Schellens CJMM, van Leeuwen MW, et al. Coagulation disorders in dogs with hepatic disease. Vet J 2009;185:163-168.
124. Shih JL, Keating JH, Freeman LM, Webster CR. Chronic hepatitis in Labrador Retrievers: Clinical presentation and prognostic factors. J Vet Intern Med 2007;21:33-39.
125. Gerritzen-Bruning MJ, van den Ingh TS, Rothuizen J. Diagnostic value of fasting plasma ammonia and bile acid concentrations in the identification of portosystemic shunting in dogs. J Vet Intern Med 2006;20:13-19.
126. Toulza O, Center SA, Brooks MB, et al. Evaluation of plasma protein C activity for detection of hepatobiliary disease and portosystemic shunting in dogs. J Am Vet Med Assoc 2006;229:1761-1771.
127. Ruland K, Fischer A, Hartmann K. Sensitivity and specificity of fasting ammonia and serum bile acids in the diagnosis of portosystemic shunts in dogs and cats. Vet Clin Pathol 2010;39:57-64.
128. Lisman T, Caldwell SH, Burroughs AK, et al. Coagulation in Liver Disease Study Group. Hemostasis and thrombosis in patients with liver disease: The ups and the downs. J Hepatol 2010;53:362-371.
129. Strombeck DR, Miller LM, Harrold D. Effects of corticosteroid treatment on survival time in dogs with chronic hepatitis: 151 cases (1977-1985). J Am Vet Med Assoc 1988;193:1109-1113.
130. Center SA, Warner K, Corbett J, et al. Protein invoked by vitamin K absence and clotting times in clinically ill cats. J Vet Intern Med 2000;14:292-297.
131. d'Anjou MA, Penninck D, Cornejo L, Pibarot P. Ultrasonographic diagnosis of portosystemic shunting in dogs and cats. Vet Radiol Ultrasound 2004;45:424-437.
132. Morandi F, Sura PA, Sharp D, Daniel GB. Characterization of multiple acquired portosystemic shunts using transplenic portal scintigraphy. Vet Rad Ultrasound 2010;51:466-471.
133. Kantrowitz BM, Nyland TG, Fisher P. Estimation of portal blood flow using duplex real-time and pulsed Doppler ultrasound imaging in the dog. Vet Rad 1989;30:222-226.
134. Lamb CR, Mahone PN. Comparison of three methods for calculating portal blood flow velocity in dogs using duplex-Doppler ultrasonography. Vet Radiol Ultrasound 1994;35:190-194.
135. Nyland TG, Fisher PE. Evaluation of experimentally induced canine hepatic cirrhosis using duplex Doppler ultrasound. Vet Radiol 1990;31:189-194.
136. Robinson KA, Middleton WD, AL-Sukaiti R, et al. Doppler sonography of portal hypertension. Ultrasound Q 2009;25:3-13.
137. Daniel GB. Scintigraphic diagnosis of portosystemic shunts. Vet Clin North Am Small Anim Pract 2009;39:793-810.
138. Gaschen L. Update on hepatobiliary imaging. Vet Clin North Am Small Anim Pract 2009;39:439-467.
139. Schmidt S, Suter PF. Angiography of the hepatic and portal venous system in the dog and cat: An investigative method. Vet Radiol 1980;21:57-77.
140. Zwingenberger A. CT diagnosis of portosystemic shunts. Vet Clin North Am Small Anim Pract 2009;39:783-792.
141. Frank P, Mahaffey M, Egger C, Cornell KK. Helical computed tomographic portography in ten normal dogs and ten dogs with a portosystemic shunt. Vet Radiol Ultrasound 2003;44:392-400.
142. Zwingenberger AL, McLear RC, Weisse C. Diagnosis of arterioportal fistulae in four dogs using computed tomographic angiography. Vet Radiol Ultrasound 2005;46:472-477.
143. Liu H, Cao H, Wu ZY. Magnetic resonance angiography in the management of patients with portal hypertension. Hepatobiliary Pancreat Dis Int 2005;4:239-243.
144. Sharpley J, Thode H, Sestina L, et al. Distal abdominal aortic thrombosis diagnosed by three-dimensional contrast-enhanced magnetic resonance angiography. Vet Radiol Ultrasound 2009;50:370-375.
145. Fischetti AJ, Kovak J. Imaging diagnosis: Azygous continuation of the caudal vena cava with and without portocaval shunting. Vet Radiol Ultrasound 2008;49:573-576.
146. Mai W. Multiphase time-resolved contrast-enhanced portal MRA in normal dogs. Vet Radiol Ultrasound 2009;50:52-57.
147. Cole TL, Center SA, Flood SN, et al. Diagnostic comparison of needle and wedge biopsy specimens of the liver in dogs and cats. J Am Vet Med Assoc 2002;220:1483-1490.
148. Díaz-Espiñeira MM, Vink-Nooteboom M, van den Ingh TS, Rothuizen J. Thrombosis of the portal vein in a miniature schnauzer. J Small Anim Pract 1999;40:540-543.
149. Willard MD, Bailey MQ, Hauptman J, Mullaney T. Obstructed portal venous flow and portal vein thrombus in a dog. J Am Vet Med Assoc 1989;2004:1449-1451.
150. Rogers CL, O'Toole TE, Keating JH, et al. Portal vein thrombosis in cats: 6 cases (2001-2006). J Vet Intern Med 2008;22:282-287.
151. Laurenson MP, Hopper K, Herrera MA, Johnson EG. Concurrent diseases and condition in dogs with splenic vein thrombosis. J Vet Intern Med 2010;24:1298-1304.
152. Wanless IR. Vascular disorders. In: Burt AD, Portmann BC, Ferrell LD, eds. MacSween's Pathology of the Liver, 5th ed. China: Elsevier; 2007:613-648.
153. van den Ingh TS, Rothuizen J. Lobular dissecting hepatitis in juvenile and young adult dogs. J Vet Intern Med 1994;8:217-220.
154. Bennett AM, Davies JD, Gaskell CJ, Lucke VM. Lobular dissecting hepatitis in the dog. Vet Pathol 1983;20:179-288.
155. Jensen AL, Nielsen OL. Chronic hepatitis in three young standard poodles. Zentralbl Veterinarmed A 1991;38:194-297.
156. Last RD, Hill JM, Roach M, Kaldenberg T. Congenital dilatation of the large and segmental intrahepatic bile ducts (Caroli's disease) in two Golden Retriever littermates. J S AFR Vet Assoc 2006;77:210-214.
157. Cave TA, Martineau H, Dickie A, et al. Idiopathic hepatic veno-occlusive disease causing Budd-Chiari-like syndrome in a cat. J Small Anim Pract 2002;43:411-415.
158. Rush JE, Freeman LM, Fenollosa NK, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc 2002;220:202-207.
159. Langdon P, Cohn L, Kreeger JM, Piddy NH. Acquired portosystemic shunting in 2 cats. J Am Anim Hosp Assoc 2002;38:21-27.
160. Gagne JM, Armstrong PJ, Weiss DJ, et al. Clinical features of inflammatory liver disease in cats: 41 cases (1983-1993). J Am Vet Med Assoc 1999;214:513-516.
161. Center SA. Diseases of the gallbladder and biliary tree. Vet Clin North Am Small Anim Pract 2009;39:543-598.
162. Gores BR, Berg J, Carpenter JL, Ullman SL. Chylous ascites in cats: Nine cases (1978-1993). J Am Vet Med Assoc 1994;205:1161-1164.
163. Edwards DF, McCracken MD, Richardson DC. Sclerosing cholangitis in a cat. J Am Vet Med Assoc 1983;182:710-712.
164. Nakayama H, Uchida K, Lee SK, et al. Three cases of feline sclerosing lymphocytic cholangitis. J Vet Med Sci 1992;54:769-771.
165. Lucke VM, Davies JD. Progressive lymphocytic cholangitis in the cat. J Small Anim Pract 1984;25:249-260.
166. Runyon BA. AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: An update. Hepatology 2009;49:2087-2107.
167. Weber FL, Fresard KM, Lally BR. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects. Gastroenterology 1982;82:213-217.
168. Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manage 2009;5:617-626.
169. Venturini AP. Pharmacokinetics of L/105, a new rifamycin, in rats and dogs, after oral administration. Chemotherapy 1983;29:1-3.
170. Center SA. Nutritional support for dogs and cats with hepatobiliary disease. J Nutr 1998;128:S2733-S2746.
171. Proot S, Biourge V, Teske E, Rothuizen J. Soy protein isolate versus meat-based low-protein diet for dogs with congenital portosystemic shunts. J Vet Intern Med 2009;23:794-800.
172. Henderson AK, Webster CRL. Use of gastroprotectants in treating gastric ulceration in dogs. Compend Continuing Educ Pract Vet 2006;28:358-370.
173. Willems B, Villeneuve JP, Huet PM. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation. Hepatology 1986;6:92-97.
174. Leung FW, Jensen DM, Guth PH. Endoscopic demonstration that vasopressin but not propranolol produces gastric mucosal ischemia in dogs with portal hypertension. Gastrointest Endosc 1988;34:310-316.
175. Alexander B, Blumgart LH, Mathie RT. The effect of propranolol on the hyperaemic response of the hepatic artery to portal venous occlusion in the dog. Br J Pharmacol 1989;96:356-362.
176. Bosch J. Carvedilol for portal hypertension in patients with cirrhosis. Hepatology 2010;51:2214-2218.
177. Robben JH, van den Brom WE, Mol JA, et al. Effect of octreotide on plasma concentrations of glucose, insulin, glucagon, growth hormone, and cortisol in healthy dogs and dogs with insulinoma. Res Vet Sci 2006;80:25-32.
178. Oberkirchner U, Linder KE, Zadrozny L, Olivry T. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide. Vet Dermatol 2010;21:510-516.
179. Minor MA, Grace ND. Pharmacologic therapy of portal hypertension. Clin Liver Dis 2006;10:563-851.
180. Groszmann RJ, Kravetz D, Bosch J, et al. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 1982;2:757-762.
181. Abraldes JG, Albillos A, Bañares R, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: A randomized controlled trial. Gastroenterology 2009;136:1651-1658.
182. Trebicka J, Hennenberg M, Laleman Wiecker E, et al. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 2007;46:242-253.
183. Zafra C, Abraldes JG, Turnes J, et al. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology 2004;126:749-755.
184. Thomason JD, Flatland B, Calvert CA. Hyperlipidemia in dogs and cats. Vet Med 2007;102:588-599.
185. Yuki M, Hirano T. Use of a combination of prednisolone and rosuvastatin for treatment of a pyogranuloma in a dog. J Am Vet Med Assoc 2010;236:767-769.
186. Vuppalanchi R, Teal E, Chalasani N. Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes. Am J Med Sci 2005;329:62-65.
187. Tandon P, Abraldes JG, Berzigotti A, et al. Renin-angiotensin-aldosteron inhibitors in the reduction of portal pressure: A systematic review and meta-analysis. J Hepatol 2010;53:273-282.
188. Deng A, Miracle CM, Suarez JM, et al. Oxygen consumption in the kidney: Effects of nitric oxide synthase isoforms and angiotensin II. Kidney Int 2005;68:723-730.
189. Xu Y, Menon V, Jugdutt BI. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins. J Renin Angiotensin Aldosterone Syst 2000;1:184-195.
190. Feng HQ, Weymouth ND, Rockey DC. Endothelin antagonism in portal hypertensive mice: Implications for endothelin receptor-specific signaling in liver disease. Am J Physiol Gastrointest Liver Physiol 2009;297:G27-G33.
191. Fernandez M, Mejias M, Garcia-Pras E, et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 2007;46:1208-1217.
192. Mejias M, Garcia-Pras E, Tiani C, et al. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009;49:1245-1256.
193. Tapper EB, Knowles D, Heffron T, et al. Portopulmonary hypertension: Imatinib as a novel treatment and the Emory experience with this condition. Transplant Proc 2009;41:1969-1971.
194. London CA. Tyrosine kinase inhibitors in veterinary medicine. Top Comp Anim Med 2009;24:106-112.